Publication | Closed Access

Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age

VaccinationVaccine SafetyVaccine DevelopmentPathogenesisBangladeshi AdultsInfection ControlPolyvalent VaccineMedicineVaccine ResearchEpidemiologyImmunogenicity Study